Suscribirse

QiDiTangShen granules modulated the gut microbiome composition and improved bile acid profiles in a mouse model of diabetic nephropathy - 19/12/20

Doi : 10.1016/j.biopha.2020.111061 
Huili Wei a, 1, Lin Wang a, 1, Zhichao An a, Huidi Xie a, Weijing Liu a, b, Qing Du a, Yan Guo a, Xi Wu a, Sicheng Li a, Yang Shi a, Xianhui Zhang a, c, , Hongfang Liu a, b,
a Department of Endocrinology and Nephrology, Renal Research Institute of Beijing University of Chinese Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Haiyuncang Road No. 5, Beijing, 100700, China 
b Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Haiyuncang Road No. 5, Beijing, 100700, China 
c Health Management Center, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Dongsibei Road No. 279, Dongcheng District, Beijing, 100700, China 

Corresponding authors at: Department of Endocrinology and Nephrology, Renal Research Institute of Beijing University of Chinese Medicine, Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine, Haiyuncang Road No. 5, Beijing, 100700, China.Department of Endocrinology and NephrologyRenal Research Institute of Beijing University of Chinese MedicineDongzhimen Hospital Affiliated to Beijing University of Chinese MedicineHaiyuncang Road No. 5Beijing100700China

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

páginas 15
Iconografías 11
Vídeos 0
Otros 0

Graphical abstract

Schematic representation of the mechanisms of QiDiTangShen granules (QDTS) in attenuating diabetic nephropathy. QDTS treatment modulated gut microbiota (GM) that was associated with BA metabolism, and reversed the increase in the serum levels of BA profiles, thereby ameliorating DN. However, QDTS treatment had no significant effect on the renal expression of FXR, other mechanisms may be involved in the renal protection of QDTS via the gut microbiota-BA axis. β-MCA, β-muricholic acid; ; TβMCA, tauro β-muricholic acid; TCA, taurocholic acid; DCA, deoxycholic acid; TBA, total bile acid; FXR, FXR; DN, diabetic nephropathy.




El texto completo de este artículo está disponible en PDF.

Highlights

QDTS exhibit beneficial effects in ameliorating diabetic nephropathy.
QDTS modulate gut microbiota and decrease serum levels of bile acids in db/db mice.
Several genera taxa and bile acids are associated with indicators of renal injury.
The gut microbiota–bile acid axis is a potential mechanism for QDTS in treating DN.

El texto completo de este artículo está disponible en PDF.

Abstract

QiDiTangShen granules (QDTS), a traditional Chinese herbal medicine, have been used in clinical practice for treating diabetic kidney disease for several years. In our previous study, we have demonstrated that QDTS displayed good efficacy on reducing proteinuria in mice with diabetic nephropathy (DN). However, the exact mechanism by which QDTS exerts its reno-protection remains largely unknown. To ascertain whether QDTS could target the gut microbiota-bile acid axis, the db/db mice were adopted as a mouse model of DN. After a 12-week of treatment, we found that QDTS significantly reduced urinary albumin excretion (UAE), and attenuated the pathological injuries of kidney in the db/db mice, while the body weight and blood glucose levels of those mice were not affected. In addition, we found that QDTS significantly altered the gut microbiota composition, and decreased serum levels of total bile acid (TBA) and BA profiles such as β-muricholic acid (β-MCA), taurocholic acid (TCA), tauro β-muricholic acid (Tβ-MCA) and deoxycholic acid (DCA). These BAs are associated with the activation of farnesoid X receptor (FXR), which is highly expressed in kidney. However, there was no significant difference between QDTS-treated and -untreated db/db mice regarding the renal expression of FXR, indicating that other mechanisms may be involved. Conclusively, our study revealed that QDTS significantly alleviated renal injuries in mice with DN. The gut microbiota-bile acid axis may be an important target for the reno-protection of QDTS in DN, but the specific mechanism merits further study.

El texto completo de este artículo está disponible en PDF.

Keywords : QiDiTangShen granules, Diabetic nephropathy, Gut Microbiota, Bile acids


Esquema


© 2020  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 133

Artículo 111061- janvier 2021 Regresar al número
Artículo precedente Artículo precedente
  • ENNAACT is a novel tool which employs neural networks for anticancer activity classification for therapeutic peptides
  • Patrick Brendan Timmons, Chandralal M. Hewage
| Artículo siguiente Artículo siguiente
  • Sophoricoside from Sophora japonica ameliorates allergic asthma by preventing mast cell activation and CD4+ T cell differentiation in ovalbumin-induced mice
  • Byung-Hak Kim, Sanghyun Lee

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
La compra de artículos no está disponible en este momento.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.